Ace Therapeutics is an expert in the field of liver disease. We aim to provide the most advanced and comprehensive vaccine development services to liver disease investigators.
Vaccines are usually biological agents made from pathogenic microorganisms and tumor cells, that can cause specific immunity in the body. Studies have found that vaccines demonstrate good therapeutic effects in areas such as hepatitis virus and liver cancer. Therefore, we offer quality services for the development of vaccines for the treatment of liver diseases to facilitate the progress of your liver disease vaccine research.
What Can We Do?
Combining the characteristics of different types of liver diseases, based on our professional team and advanced technology platform, we provide comprehensive vaccine development services mainly for two aspects of viral hepatitis and liver cancer.
- Vaccine Development for Viral Hepatitis
Hepatitis virus vaccines are the most effective means of preventing and treating hepatitis virus infections worldwide. However, vaccine development is difficult due to high antigenic variability, immune escape ability, and other reasons. We provide quality services to meet the needs of different investigators.
- We have an extensive cell bank. We can select suitable cells for virus culture according to virus species, vaccine nature, and preparation process.
- We have proven technology to produce virulent strains of appropriate virulence by cell culture.
- We have established standard methods for different routes of immunogen vaccination, which can ensure the best immunization effect.
- We have a well-established vaccine development platform for the preparation of different types of vaccines.
- Vaccine Development for Liver Cancer
Cancer vaccines are a novel strategy for inducing or reactivating anti-tumor immune responses. However, issues such as the great variability of tumor antigens hinder their clinical use. To expand the clinical use of vaccines in the field of liver cancer, we offer different services to facilitate the development of liver cancer vaccines.
- We can identify novel TAAs by high-throughput techniques and analyze them by immunoinformatics algorithms to predict specific epitopes interacting with MHC complexes.
- We can perform direct sequencing of HLA molecule-presenting peptides in tumor cells based on high-resolution mass spectrometry to identify naturally processed class I and class II tumor-associated peptides.
- We can structure-based prediction methods to be broadly applicable to different types of MNC and TCR receptors.
- We have proven technologies for the preparation of different types of antigens to meet the needs of different types of vaccine preparation.
- We have advanced vaccine platforms that allow us to develop and optimize different types of vaccines.
Based on our rich hands-on experience and advanced vaccine platform, Ace Therapeutics is committed to providing you with high-quality and efficient vaccine development services for liver diseases. If you would like to learn more about our services, please feel free to contact us.
Related Services
Our products and services are for research use only and can not be used for diagnostic or other purposes.
